Lipid Second Messengers

Regular price €137.99
Quantity:
In stock with our UK publisher. 14-28 days
Delivery/Collection within 10-20 working days
14 days return policy Shipping & Delivery
Category=PSAN
Category=PSB
Cayman Chemical
Cos-1 Cells
Cyclooxygenase Active Site
Cyclooxygenase Activity
eicosanoid biosynthesis
ELISA Buffer
enzyme activity assays
eq_bestseller
eq_isMigrated=1
eq_isMigrated=2
eq_nobargain
eq_non-fiction
eq_science
fatty acylethanolamides analysis
Glycosyl Phosphatidylinositol Specific PLD
Hep G2 Cell
HEPES Tyrode Buffer
lipid mediator quantification
lipid signaling pathways
molecular pharmacology research
Neutral SMase
Normal Phase HPLC
Nu Check Prep
Nuclease Free Water
Oxygen Electrode
PGG
Phosphatidic Acid
PLD Activity
Round Bottomed Glass Flask
SM Hydrolysis
SM Level
SMase Activity
sphingolipid metabolism
Time Dependent Inhibition
TLC Plate
Transcellular Biosynthesis
Vitro Assays
Voltage Clamp Recording

Product details

  • ISBN 9780849333835
  • Weight: 235g
  • Dimensions: 152 x 229mm
  • Publication Date: 17 Nov 1998
  • Publisher: Taylor & Francis Inc
  • Publication City/Country: US
  • Product Form: Paperback
Secure checkout Fast Shipping Easy returns
Lipid Second Messengers provides detailed methodology for analysis of various lipid signaling pathways. Authoritative contributors explain the factors that regulate lipid second messenger production by agonist-activated enzymes and examine their products. Topics discussed include procedures used to measure lipid-derived mediators such as lysophospholipids, arachidonic acid, eicosanoids, anandamide, and ceramides, and the enzymes responsible for generating these messengers, such as phospholipases, prostaglandin endoperoxide synthases, and sphingomyelinase.
Suzanne Laychock, Ph.D., is Professor and Associate Chair of the Department of Pharmacology & Toxicology at the State University of New York at Buffalo, School of Medicine and Biomedical Sciences. She has been studying signal transduction mechanisms involving phospholipases, fatty acids, and eicosanoids since 1975. A major thrust of her work has been in defining the role of phospholipid hydrolysis and turnover, and prostaglandin synthesis in the control of endocrine cells. Her early pioneering work focused on the radioimmunoassay of prostaglandins and the characterization of calcium-dependent phospholipase A2 in adrenocortical cells and isolated pancreatic islets. Her laboratory was also the first to demonstrate calcium regulation of phospholipase C-mediated hydrolysis of phosphoinositides. Dr. Laychock has published over 60 full publications and written three reviews and seven book chapters. She has served as a member of the Editorial Board of several prestigious journals. Ronald P. Rubin, Ph.D., is Professor and Chair of the Department of Pharmacology & Toxicology at the State University of New York at Buffalo, School of Medicine and Biomedical Sciences. Dr. Rubin conducted pioneering work on the pivotal role of calcium in stimulus-response coupling in secretory cells. In addition, he has published widely on the role of lipid mediators in regulating the secretory process in a number of different cell types, including adrenocortical cells, pancreatic and parotid acinar cells, and neutrophils. His current research involves the signal transduction processes associated with the regulation of calcium signaling in parotid acinar cells. Dr. Rubin has published over 100 full publications, written several reviews, and authored two monographs. He also coedited a volume on Calcium in Biological Systems.